Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulinum toxin A vs platelet-rich plasma for male androgenetic alopecia (half-head randomized-sided study)
TCTR20251220009Phase 3Active, not recruiting
- Sponsor
- MNB
- Start
- Sep 2025
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A, platelet-rich plasma in androgenetic alopecia (AGA), sponsored by MNB. Started Sep 2025; status: active, not recruiting.
02
Drugs
botulinum toxin type Aplatelet-rich plasma
03
Conditions
androgenetic alopecia (AGA)
Beyond the preview
Go deeper on TCTR20251220009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20251220009.